Categories Earnings, Industrials

Tesla’s stock gains on better-than-expected Q4 vehicle deliveries

Shares of Tesla Inc. (NASDAQ: TSLA) were up 3.7% in midday trade on Friday after the company reported fourth quarter 2019 vehicle deliveries that were ahead of analysts’ estimates.

During the quarter, Tesla achieved production of 104,891 vehicles and deliveries of 112,000 vehicles. In 2019, deliveries totaled approx. 367,500 vehicles, which was up 50% compared to the previous year and in line with the company’s guidance.

In the fourth quarter, Tesla produced 17,933 Model S/X vehicles and 86,958 Model 3 vehicles. The company delivered 19,450 Model S/X vehicles and 92,550 Model 3 vehicles during the period.

(Image Courtesy: Afif Kusuma/Unsplash)

This compares to total production of 96,155 vehicles and deliveries of 97,000 vehicles in the third quarter of 2019. The company produced 16,318 Model S/X vehicles and 79,837 Model 3 vehicles during the period while deliveries totaled 17,400 vehicles for Model S/X and 79,600 vehicles for Model 3.

In its third quarter 2019 earnings announcement, Tesla had guided for deliveries in excess of 360,000 for the year.

Tesla said it is focusing on expanding production in the US as well as its new facility in Shanghai. The company has produced almost 1,000 customer salable cars at Gigafactory Shanghai and has commenced deliveries. Tesla also said it demonstrated production run-rate capability of more than 3,000 units per week.

Over the past one year, Tesla’s shares have gained 40%.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top